ASX Filings

Opthea Key Opinion Leader Even on Sozinibercept

April 4, 2024

Notification regarding unquoted securities - OPT

April 2, 2024

Opthea to Host Key Opinion Leader Event on April 3, 2024

March 19, 2024

Opthea to Participate in Leerink Global Biopharma Conference

March 6, 2024

Opthea Corporate Presentation - March 2024

March 4, 2024

Change of Director's Interest Notice Update

March 1, 2024

Change of Director's Interest Notice

March 1, 2024

Opthea Reports Half-Year Results and Business Update

February 29, 2024

Half Yearly Report and Accounts

February 29, 2024

Opthea Appoints Arshard M Khanani as Chief Medical Advisor

February 20, 2024